Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leony Antoun

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Health Behavior|April 17, 2020
Duchenne Smile is Associated with Quality of Life and Survival in Hemodialysis PatientsMabel Aoun, Ghassan Sleilaty, Leony Antoun, et al.
Plos One|January 23, 2018
Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?Mabel Aoun, Rita Karam, Ghassan Sleilaty, et al.
Asian Pacific Journal of Tropical Medicine|September 26, 2017
Brucellosis: A lymphoma-like presentationMarcel Massoud, Fouad Kerbage, Leony Antoun, et al.
Plos One|October 3, 2017
Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational studyMabel Aoun, Sahar H Koubar, Leony Antoun, et al.
BMC Public Health|October 10, 2021
Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019Elsie Touma, Leony Antoun, Souheil Hallit, et al.
Life (Basel, Switzerland)|August 28, 2025
Prediction of Breast Cancer Response to Neoadjuvant Therapy with Machine Learning: A Clinical, MRI-Qualitative, and Radiomics ApproachRami Hajri, Charles Aboudaram, Nathalie Lassau, et al.
Cancers|September 28, 2023
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available TreatmentsMarine Valery, Damien Vasseur, Francesco Fachinetti, et al.
Biomedicines|September 28, 2023
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsAnthony Tarabay, Alice Boileve, Cristina Smolenschi, et al.
Future Oncology (London, England)|February 10, 2025
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patientsRoland Eid, Anthony Tarabay, Pierre Decazes, et al.
Hemasphere|August 23, 2021
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast CancersSabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Health Behavior|April 17, 2020
Duchenne Smile is Associated with Quality of Life and Survival in Hemodialysis PatientsMabel Aoun, Ghassan Sleilaty, Leony Antoun, et al.
Plos One|January 23, 2018
Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?Mabel Aoun, Rita Karam, Ghassan Sleilaty, et al.
Asian Pacific Journal of Tropical Medicine|September 26, 2017
Brucellosis: A lymphoma-like presentationMarcel Massoud, Fouad Kerbage, Leony Antoun, et al.
Plos One|October 3, 2017
Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational studyMabel Aoun, Sahar H Koubar, Leony Antoun, et al.
BMC Public Health|October 10, 2021
Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019Elsie Touma, Leony Antoun, Souheil Hallit, et al.
Life (Basel, Switzerland)|August 28, 2025
Prediction of Breast Cancer Response to Neoadjuvant Therapy with Machine Learning: A Clinical, MRI-Qualitative, and Radiomics ApproachRami Hajri, Charles Aboudaram, Nathalie Lassau, et al.
Cancers|September 28, 2023
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available TreatmentsMarine Valery, Damien Vasseur, Francesco Fachinetti, et al.
Biomedicines|September 28, 2023
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsAnthony Tarabay, Alice Boileve, Cristina Smolenschi, et al.
Future Oncology (London, England)|February 10, 2025
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patientsRoland Eid, Anthony Tarabay, Pierre Decazes, et al.
Hemasphere|August 23, 2021
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast CancersSabine Khalife-Hachem, Khalil Saleh, Florence Pasquier, et al.
Pageof 2